1-7 of 7
Julia Mohr
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

DNA damage–induced transcriptional program in CLL: biological and diagnostic implications for functional p53 testing

Julia Mohr, Hanne Helfrich, Maxi Fuge, Eric Eldering, Andreas Bühler, Dirk Winkler, Matthias Volden, Arnon P. Kater, Daniel Mertens, Doreen Te Raa, Hartmut Döhner, Stephan Stilgenbauer, Thorsten Zenz
Journal: Blood
Blood (2011) 117 (5): 1622–1632.
https://doi.org/10.1182/blood-2010-08-300160
Published: 2011
Includes: Supplemental data
Journal Articles

Comprehensive Protein Expression Analysis of Chronic Lymphocytic Leukemia Uncovers a Correlation of CDK4, P27 and P53 with Hierarchical Risk and Suggests a Dichotomy of Apoptosis and Proliferation.

Dirk Winkler, MD, Christof Schneider, MD, Daniela Nitsch, MD, Kerstin Schulze, Thorsten Zenz, MD, Julia Mohr, Andreas Buehler, MD, Annett Habermann, Manuela Zucknick, Axel Benner, Hartmut Döhner, MD, Stephan Stilgenbauer, MD, Daniel Mertens
Journal: Blood
Blood (2009) 114 (22): 1255.
https://doi.org/10.1182/blood.V114.22.1255.1255
Published: 2009
Journal Articles

Detailed analysis of p53 pathway defects in fludarabine-refractory chronic lymphocytic leukemia (CLL): dissecting the contribution of 17p deletion, TP53 mutation, p53-p21 dysfunction, and miR34a in a prospective clinical trial

Clinical Trials & Observations
Thorsten Zenz, Sonja Häbe, Tina Denzel, Julia Mohr, Dirk Winkler, Andreas Bühler, Antonio Sarno, Silja Groner, Daniel Mertens, Raymonde Busch, Michael Hallek, Hartmut Döhner, Stephan Stilgenbauer
Journal: Blood
Blood (2009) 114 (13): 2589–2597.
https://doi.org/10.1182/blood-2009-05-224071
Published: 2009
Includes: Supplemental data
Journal Articles

miR-34a as part of the resistance network in chronic lymphocytic leukemia

Thorsten Zenz, Julia Mohr, Eric Eldering, Arnon P. Kater, Andreas Bühler, Dirk Kienle, Dirk Winkler, Jan Dürig, Marinus H. J. van Oers, Daniel Mertens, Hartmut Döhner, Stephan Stilgenbauer
Journal: Blood
Blood (2009) 113 (16): 3801–3808.
https://doi.org/10.1182/blood-2008-08-172254
Published: 2009
Includes: Supplemental data
Journal Articles

The Response to DNA Damage in CLL Cells Is Partly Determined by the Type of TP53 Mutation and Genomic Aberrations

Julia Mohr, Thorsten Zenz, Dirk Winkler, Andreas Bühler, Daniel Mertens, Hartmut Döhner, Stephan Stilgenbauer, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 3119.
https://doi.org/10.1182/blood.V112.11.3119.3119
Published: 2008
Journal Articles

Mir-34a as Part of the Chemotherapy Resistance Network in Chronic Lymphocytic Leukemia.

Thorsten Zenz, Julia Mohr, Eric Eldering, Arnon P Kater, Andreas Bühler, Dirk Winkler, Dirk Kienle, Jan Dürig, Daniel Mertens, Hartmut Döhner, Stephan Stilgenbauer
Journal: Blood
Blood (2008) 112 (11): 1209.
https://doi.org/10.1182/blood.V112.11.1209.1209
Published: 2008
Journal Articles

17p Deletion in CLL: Detailed Analysis of TP53 Mutations, Alternative Mechanisms of p53 Inactivation, Clone Size and Clonal Evolution

Thorsten Zenz, Antonio Sarno, Sonja Häbe, Tina Denzel, Julia Mohr, Dominik Vollmer, Maria Heuberger, Dirk Winkler, Dirk Kienle, Andreas Bühler, Sim Truong, Nancy Patten, Michael Hallek, Hartmut Döhner, Stephan Stilgenbauer
Journal: Blood
Blood (2008) 112 (11): 782.
https://doi.org/10.1182/blood.V112.11.782.782
Published: 2008